Bradley William Guy, Holm Katharine Nichole, Tanaka Akiko
Tampa Bay Research Institute, 10900 Roosevelt Blvd N, St, Petersburg, FL 33716, USA.
BMC Complement Altern Med. 2014 May 22;14:163. doi: 10.1186/1472-6882-14-163.
We have previously demonstrated that an alkaline extract of shredded pinecones yields a polyphenylpropanoid polysaccharide complex (PPC) that functions as an orally active immune adjuvant. Specifically, oral PPC can boost the number of antigen-specific memory CD8+ T cells generated in response to a variety of vaccine types (DNA, protein, and dendritic cell) and bias the response towards one that is predominately a T helper 1 type.
An immune response was initiated by intraperitoneal injection of mice with Staphylococcus enterotoxin B (SEB). A group of mice received PPC by gavage three times per day on Days 0 and 1. The draining lymph nodes were analyzed 48-96 h post-injection for the numbers of reactive T cells, cytokine production, the generation of reactive oxygen species, and apoptotsis.
In this study we examined whether the ability of PPC to boost a T cell response is due to an effect on the proliferative or contraction phases, or both, of the primary response. We present data to demonstrate that oral PPC significantly enhances the primary T cell response by affecting the expansion of T cells (both CD4 and CD8) during the proliferative phase, while having no apparent effects on the activation-induced cell death associated with the contraction phase.
These findings suggest that PPC could potentially be utilized to enhance the T cell response generated by a variety of prophylactic and therapeutic vaccines designed to target a cellular response.
我们之前已经证明,松果体碎片的碱性提取物可产生一种聚苯丙素多糖复合物(PPC),它作为一种口服活性免疫佐剂发挥作用。具体而言,口服PPC可以增加针对多种疫苗类型(DNA、蛋白质和树突状细胞)产生的抗原特异性记忆CD8+T细胞的数量,并使免疫反应偏向于主要为T辅助1型的反应。
通过向小鼠腹腔注射肠毒素B(SEB)引发免疫反应。一组小鼠在第0天和第1天每天通过灌胃给予PPC三次。在注射后48 - 96小时分析引流淋巴结中反应性T细胞的数量、细胞因子产生、活性氧的生成以及细胞凋亡情况。
在本研究中,我们检查了PPC增强T细胞反应的能力是否归因于对初次反应的增殖或收缩阶段,或两者的影响。我们提供的数据表明,口服PPC通过影响增殖阶段T细胞(CD4和CD8)的扩增显著增强初次T细胞反应,而对与收缩阶段相关的活化诱导细胞死亡没有明显影响。
这些发现表明,PPC可能潜在地用于增强多种旨在引发细胞反应的预防性和治疗性疫苗所产生的T细胞反应。